A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,582 shares of HALO stock, worth $273,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,582
Previous 3,800 20.58%
Holding current value
$273,316
Previous $198,000 32.32%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$51.3 - $64.42 $40,116 - $50,376
782 Added 20.58%
4,582 $262,000
Q2 2024

Jul 30, 2024

SELL
$37.81 - $52.4 $2.83 Million - $3.92 Million
-74,864 Reduced 95.17%
3,800 $198,000
Q1 2024

May 01, 2024

BUY
$33.68 - $41.95 $73,826 - $91,954
2,192 Added 2.87%
78,664 $3.2 Million
Q4 2023

Jan 24, 2024

BUY
$33.32 - $42.1 $22,457 - $28,375
674 Added 0.89%
76,472 $2.83 Million
Q3 2023

Oct 26, 2023

BUY
$36.46 - $44.03 $77,987 - $94,180
2,139 Added 2.9%
75,798 $2.9 Million
Q2 2023

Aug 10, 2023

SELL
$30.28 - $38.74 $125,056 - $159,996
-4,130 Reduced 5.31%
73,659 $2.66 Million
Q1 2023

May 04, 2023

BUY
$32.86 - $55.7 $400,333 - $678,593
12,183 Added 18.57%
77,789 $2.97 Million
Q4 2022

Feb 09, 2023

BUY
$40.06 - $59.44 $3,084 - $4,576
77 Added 0.12%
65,606 $3.73 Million
Q3 2022

Nov 10, 2022

BUY
$38.53 - $51.78 $625,958 - $841,217
16,246 Added 32.96%
65,529 $2.59 Million
Q2 2022

Jul 26, 2022

BUY
$37.35 - $48.3 $1.84 Million - $2.38 Million
49,283 New
49,283 $2.17 Million
Q4 2021

Feb 08, 2022

SELL
$31.82 - $40.75 $264,806 - $339,121
-8,322 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$38.47 - $46.42 $41,586 - $50,180
1,081 Added 14.93%
8,322 $339,000
Q2 2021

Aug 11, 2021

SELL
$38.84 - $51.31 $4,777 - $6,311
-123 Reduced 1.67%
7,241 $329,000
Q1 2021

May 13, 2021

SELL
$39.51 - $51.45 $63,808 - $83,091
-1,615 Reduced 17.99%
7,364 $307,000
Q4 2020

Feb 10, 2021

BUY
$25.81 - $43.62 $12,053 - $20,370
467 Added 5.49%
8,979 $384,000
Q3 2020

Nov 12, 2020

BUY
$25.74 - $29.63 $219,098 - $252,210
8,512 New
8,512 $224,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $8.31B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.